Leptin signalling system as a target for pulmonary arterial hypertension therapy

European Respiratory Journal

Volumn 45, Issue 4, 2015, Pages 1066-1080

  Huertas, Alice ^a,b,c   Tu, Ly ^a,b   Thuillet, Raphaël ^a,b   Le Hiress, Morane ^a,b   Phan, Carole ^a,b   Ricard, Nicolas ^a,b   Nadaud, Sophie ^d   Fadel, Elie ^a,b   Humbert, Marc ^a,b,c   Guignabert, Christophe ^a,b  

^a CENTRE CHIRURGICAL MARIE LANNELONGUE   (France)

^b UNIVERSITÉ PARIS SACLAY   (France)

^c BICÊTRE HOSPITAL   (France)

^d Institute OfCardiometabolism and Nutrition   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CELL ADHESION MOLECULE; DICHLOROACETIC ACID; LEPTIN; RECOMBINANT PROTEIN;

ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL ACTIVATION; CELL CULTURE; CELL PROLIFERATION; CONTROLLED STUDY; DISEASE PREDISPOSITION; DISEASE SEVERITY; ENDOTHELIUM CELL; FEMALE; HUMAN; HUMAN TISSUE; IN VITRO STUDY; IN VIVO STUDY; LUNG HEMODYNAMICS; LUNG PARENCHYMA; MALE; MONOCYTE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN TARGETING; PULMONARY ARTERIAL SMOOTH MUSCLE CELL; PULMONARY HYPERTENSION; RAT; SIGNAL TRANSDUCTION; SMOOTH MUSCLE FIBER; SYSTOLIC BLOOD PRESSURE; ANIMAL; ANOXIA; C57BL MOUSE; CASE CONTROL STUDY; CYTOLOGY; DISEASE MODEL; ENZYME LINKED IMMUNOSORBENT ASSAY; FAMILIAL PRIMARY PULMONARY HYPERTENSION; GENETICS; HEMODYNAMICS; HYPERTENSION, PULMONARY; METABOLISM; MIDDLE AGED; MOLECULARLY TARGETED THERAPY; PATHOPHYSIOLOGY; PHYSIOLOGY; PROCEDURES; REAL TIME POLYMERASE CHAIN REACTION; SPRAGUE DAWLEY RAT; UPREGULATION; VASCULAR REMODELING; VASCULAR SMOOTH MUSCLE; WESTERN BLOTTING;

ADULT; ANIMALS; ANOXIA; BLOTTING, WESTERN; CASE-CONTROL STUDIES; CELL PROLIFERATION; CELLS, CULTURED; DISEASE MODELS, ANIMAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; FAMILIAL PRIMARY PULMONARY HYPERTENSION; FEMALE; HEMODYNAMICS; HUMANS; HYPERTENSION, PULMONARY; LEPTIN; MALE; MICE; MICE, INBRED C57BL; MIDDLE AGED; MOLECULAR TARGETED THERAPY; MUSCLE, SMOOTH, VASCULAR; MYOCYTES, SMOOTH MUSCLE; RATS; RATS, SPRAGUE-DAWLEY; REAL-TIME POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; UP-REGULATION; VASCULAR REMODELING;

EID: 84926442171     PISSN: 09031936     EISSN: 13993003     Source Type: Journal    
DOI: 10.1183/09031936.00193014     Document Type: Article

References (51)

1. Tian W, Jiang X, Tamosiuniene R, et al. Blocking macrophage leukotriene b4 prevents endothelial injury and reverses pulmonary hypertension. Sci Transl Med 2013; 5: 200ra117.
2. Vergadi E, Chang MS, Lee C, et al. Early macrophage recruitment and alternative activation are critical for the later development of hypoxia-induced pulmonary hypertension. Circulation 2011; 123: 1986-1995.
3. Humbert M, Sitbon O, Chaouat A, et al. Survival in patients with idiopathic, familial, and anorexigen-associated pulmonary arterial hypertension in the modern management era. Circulation 2010; 122: 156-163.
4. Santos-Alvarez J, Goberna R, Sanchez-Margalet V. Human leptin stimulates proliferation and activation of human circulating monocytes. Cell Immunol 1999; 194: 6-11.
5. Yamagishi SI, Edelstein D, Du XL, et al. Leptin induces mitochondrial superoxide production and monocyte chemoattractant protein-1 expression in aortic endothelial cells by increasing fatty acid oxidation via protein kinase A. J Biol Chem 2001; 276: 25096-25100.
6. Schafer K, Halle M, Goeschen C, et al. Leptin promotes vascular remodeling and neointimal growth in mice. Arterioscler Thromb Vasc Biol 2004; 24: 112-117.
7. Huertas A, Tu L, Gambaryan N, et al. Leptin and regulatory T-lymphocytes in idiopathic pulmonary arterial hypertension. Eur Respir J 2012; 40: 895-904.
8. Beltowski J. Leptin and atherosclerosis. Atherosclerosis 2006; 189: 47-60.
9. Gomart S, Damoiseaux C, Jespers P, et al. Pulmonary vasoreactivity in spontaneously hypertensive rats - effects of endothelin-1 and leptin. Respir Res 2014; 15: 12.
10. Tonelli AR, Aytekin M, Feldstein AE, et al. Leptin levels predict survival in pulmonary arterial hypertension. Pulm Circ 2012; 2: 214-219.
11. Aytekin M, Tonelli AR, Farver CF, et al. Leptin deficiency recapitulates the histological features of pulmonary arterial hypertension in mice. Int J Clin Exp Patho 2014; 7: 1935-1946.
12. Tu L, De Man FS, Girerd B, et al. A critical role for p130Cas in the progression of pulmonary hypertension in humans and rodents. Am J Respir Crit Care Med 2012; 186: 666-676.
13. Guignabert C, Raffestin B, Benferhat R, et al. Serotonin transporter inhibition prevents and reverses monocrotaline-induced pulmonary hypertension in rats. Circulation 2005; 111: 2812-2819.
14. Izikki M, Guignabert C, Fadel E, et al. Endothelial-derived FGF2 contributes to the progression of pulmonary hypertension in humans and rodents. J Clin Invest 2009; 119: 512-523.
15. Schroeter MR, Leifheit M, Sudholt P, et al. Leptin enhances the recruitment of endothelial progenitor cells into neointimal lesions after vascular injury by promoting integrin-mediated adhesion. Circ Res 2008; 103: 536-544.
16. Karamouti M, Kollia P, Kallitsaris A, et al. Modulating effect of leptin on basal and follicle stimulating hormone stimulated steroidogenesis in cultured human lutein granulosa cells. J Endocrinol Invest 2009; 32: 415-419.
17. Sirotkin AV, Mlyncek M, Makarevich AV, et al. Leptin affects proliferation-, apoptosis- and protein kinase A-related peptides in human ovarian granulosa cells. Physiol Res 2008; 57: 437-442.
18. Kim KS, Yoon YR, Lee HJ, et al. Enhanced hypothalamic leptin signaling in mice lacking dopamine D2 receptors. J Biol Chem 2010; 285: 8905-8917.
19. De Rosa V, Procaccini C, La Cava A, et al. Leptin neutralization interferes with pathogenic T cell autoreactivity in autoimmune encephalomyelitis. J Clin Investig 2006; 116: 447-455.
20. Ricard N, Tu L, Le Hiress M, et al. Increased pericyte coverage mediated by endothelial-derived fibroblast growth factor-2 and interleukin-6 is a source of smooth muscle-like cells in pulmonary hypertension. Circulation 2014; 129: 1586-1597.
21. Tu L, Dewachter L, Gore B, et al. Autocrine fibroblast growth factor-2 signaling contributes to altered endothelial phenotype in pulmonary hypertension. Am J Respir Cell Mol Biol 2011; 45: 311-322.
22. Guignabert C, Tu L, Izikki M, et al. Dichloroacetate treatment partially regresses established pulmonary hypertension in mice with SM22α-targeted overexpression of the serotonin transporter. FASEB J 2009; 23: 4135-4147.
23. Ambrosini G, Nath AK, Sierra-Honigmann MR, et al. Transcriptional activation of the human leptin gene in response to hypoxia. Involvement of hypoxia-inducible factor 1. J Biol Chem 2002; 277: 34601-34609.
24. Otero M, Lago R, Lago F, et al. Leptin, from fat to inflammation: old questions and new insights. FEBS Lett 2005; 579: 295-301.
25. Semenza GL. Hypoxia-inducible factors in physiology and medicine. Cell 2012; 148: 399-408.
26. Michelakis ED, McMurtry MS, Wu XC, et al. Dichloroacetate, a metabolic modulator, prevents and reverses chronic hypoxic pulmonary hypertension in rats: role of increased expression and activity of voltage-gated potassium channels. Circulation 2002; 105: 244-250.
27. Sutendra G, Dromparis P, Kinnaird A, et al. Mitochondrial activation by inhibition of PDKII suppresses HIF1a signaling and angiogenesis in cancer. Oncogene 2013; 32: 1638-1650.
28. Bonnet S, Michelakis ED, Porter CJ, et al. An abnormal mitochondrial-hypoxia inducible factor-1α-Kv channel pathway disrupts oxygen sensing and triggers pulmonary arterial hypertension in fawn hooded rats: similarities to human pulmonary arterial hypertension. Circulation 2006; 113: 2630-2641.
29. Yu AY, Shimoda LA, Iyer NV, et al. Impaired physiological responses to chronic hypoxia in mice partially deficient for hypoxia-inducible factor 1alpha. J Clin Investig 1999; 103: 691-696.
30. Brusselmans K, Compernolle V, Tjwa M, et al. Heterozygous deficiency of hypoxia-inducible factor-2α protects mice against pulmonary hypertension and right ventricular dysfunction during prolonged hypoxia. J Clin Investig 2003; 111: 1519-1527.
31. Shimoda LA, Semenza GL. HIF and the lung: role of hypoxia-inducible factors in pulmonary development and disease. Am J Respir Crit Care Med 2011; 183: 152-156.
32. Stephenson K, Tunstead J, Tsai A, et al. Neointimal formation after endovascular arterial injury is markedly attenuated in db/db mice. Arterioscler Thromb Vasc Biol 2003; 23: 2027-2033.
33. Bodary PF, Shen Y, Ohman M, et al. Leptin regulates neointima formation after arterial injury through mechanisms independent of blood pressure and the leptin receptor/STAT3 signaling pathways involved in energy balance. Arterioscler Thromb Vasc Biol 2007; 27: 70-76.
34. Lee FY, Li Y, Yang EK, et al. Phenotypic abnormalities in macrophages from leptin-deficient, obese mice. Am J Physiol 1999; 276: C386-C394.
35. Tuder RM, Archer SL, Dorfmüller P, et al. Relevant issues in the pathology and pathobiology of pulmonary hypertension. J Am Coll Cardiol 2013; 62: Suppl. 25, D4-D12.
36. Huertas A, Perros F, Tu L, et al. Immune dysregulation and endothelial dysfunction in pulmonary arterial hypertension: a complex interplay. Circulation 2014; 129: 1332-1340.
37. Rabinovitch M, Guignabert C, Humbert M, et al. Inflammation and immunity in the pathogenesis of pulmonary arterial hypertension. Circ Res 2014; 115: 165-175.
38. Stacher E, Graham BB, Hunt JM, et al. Modern age pathology of pulmonary arterial hypertension. Am J Respir Crit Care Med 2012; 186: 261-272.
39. Dorfmüller P, Humbert M. Progress in pulmonary arterial hypertension pathology: relighting a torch inside the tunnel. Am J Respir Crit Care Med 2012; 186: 210-212.
40. Frid MG, Brunetti JA, Burke DL, et al. Hypoxia-induced pulmonary vascular remodeling requires recruitment of circulating mesenchymal precursors of a monocyte/macrophage lineage. Am J Pathol 2006; 168: 659-669.
41. Tliba O, Panettieri RA Jr. Noncontractile functions of airway smooth muscle cells in asthma. Annu Rev Physiol 2009; 71: 509-535.
42. Dreymueller D, Martin C, Schumacher J, et al. Smooth muscle cells relay acute pulmonary inflammation via distinct ADAM17/ErbB axes. J Immunol 2014; 192: 722-731.
43. Archer SL, Gomberg-Maitland M, Maitland ML, et al. Mitochondrial metabolism, redox signaling, and fusion: a mitochondria-ROS-HIF-1α-Kv1.5 O2-sensing pathway at the intersection of pulmonary hypertension and cancer. Am J Physiol Heart Circ Physiol 2008; 294: H570-H578.
44. Guignabert C, Izikki M, Tu LI, et al. Transgenic mice overexpressing the 5-hydroxytryptamine transporter gene in smooth muscle develop pulmonary hypertension. Circ Res 2006; 98: 1323-1330.
45. Reeve HL, Michelakis E, Nelson DP, et al. Alterations in a redox oxygen sensing mechanism in chronic hypoxia. J Appl Physiol (1985) 2001; 90: 2249-2256.
46. + channels in pulmonary artery smooth muscle cells of patients with primary pulmonary hypertension. Circulation 1998; 98: 1400-1406.
47. Scholz CC, Taylor CT. Targeting the HIF pathway in inflammation and immunity. Curr Opin Pharmacol 2013; 13: 646-653.
48. Huertas A, Das SR, Emin M, et al. Erythrocytes induce proinflammatory endothelial activation in hypoxia. Am J Respir Cell Mol Biol 2013; 48: 78-86.
49. Rius J, Guma M, Schachtrup C, et al. NF-κB links innate immunity to the hypoxic response through transcriptional regulation of HIF-1α. Nature 2008; 453: 807-811.
50. Walmsley SR, Print C, Farahi N, et al. Hypoxia-induced neutrophil survival is mediated by HIF-1α-dependent NF-κB activity. J Exp Med 2005; 201: 105-115.
51. Lewis C, Murdoch C. Macrophage responses to hypoxia: implications for tumor progression and anti-cancer therapies. Am J Pathol 2005; 167: 627-635.